Les 10 concurrents drughunter.com les plus visités

delphiatx.com

Delphia is pioneering activation lethality - a next-generation precision medicine approach that targets cancer's surprising vulnerability to oncogene overactivation.

sygnaturediscovery.com

Discover emerging strategies that enhance drug delivery in next generation ADCs, opening new opportunities for improved clinical performance.

aligos.com

With experience in developing therapeutics for chronic liver diseases and viral infections, we are building best-in-class drug candidates.

oricpharma.com

Resistance limits the efficacy of otherwise significant cancer treatment breakthroughs, regardless of modality. Our ambition at ORIC is to develop innovative therapies that benefit patients with cancer, including by making existing therapies more effective for a longer period of time.

ptcbio.com

For Sam, publishing his first book was nerve-wracking – it chronicled his Friedreich’s ataxia (FA) diagnosis and was therefore very personal. He wasn’t sure what people would think, but he was pleased with the positive reception of his book. Sam is a passionate writer and has since published five more books. In this video, Sam…

opentargets.org

open targets is a public-private initiative to generate evidence on the validity of therapeutic targets based on genome-scale experiments and analysis.

drugpatentwatch.com

The pharmaceutical industry in 2026 stands at a critical juncture where the traditional “patent cliff”—the once-dreaded moment when a blockbuster drug’s revenue plummeted upon the arrival of generic…

insilico.com

Making history by cutting it

tamarind.bio

Accelerate discovery with top computational biology tools on Tamarind Bio. Design and score proteins, peptides, small molecules and much more. Utilize top tools such as AlphaFold, RFdiffusion, BoltzGen, GROMACS or one of our 250+ other models.